Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 47,133 | 41,848 | 41,420 | 33,161 | 27,003 |
| Cost of Goods | 11,739 | 6,353 | 7,644 | 4,683 | 1,937 |
| Gross Profit | 35,394 | 35,495 | 33,776 | 28,478 | 25,066 |
| Operating Expenses | 13,268 | 32,101 | 27,320 | 25,373 | 36,182 |
| Operating Income | 22,865 | 3,747 | 7,100 | 3,788 | -10,179 |
| Interest Expense | 6,385 | 6,269 | 6,213 | 8,548 | 8,834 |
| Other Income | -1,280 | -9,090 | 27,232 | -25,655 | 10,838 |
| Pre-tax Income | 15,200 | -11,612 | 28,119 | -30,415 | -8,175 |
| Income Tax | -144 | -4,911 | 6,033 | -6,284 | -810 |
| Net Income Continuous | 15,344 | -6,701 | 22,086 | -24,131 | -7,365 |
| Net Income | $5,761 | $-6,701 | $22,086 | $-24,131 | $-7,365 |
| EPS Basic Total Ops | 0.32 | -0.42 | 1.38 | -1.46 | 2.09 |
| EPS Basic Continuous Ops | 0.91 | -0.42 | 1.38 | -1.46 | 2.09 |
| EPS Diluted Total Ops | 0.38 | -0.42 | 1.32 | -1.46 | 2.08 |
| EPS Diluted Continuous Ops | 0.94 | -0.42 | 1.32 | -1.46 | 2.08 |
| EBITDA(a) | $40,987 | $13,905 | $16,929 | $18,201 | $16,486 |